Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study
- Auteur
- PEDERSEN, T. R1 ; BERG, K1 ; THORGEIRSSON, G8 ; TOBERT, J. A2 ; WEDEL, H9 ; WIHELMSEN, L9 ; COOK, T. J2 ; FOERGEMAN, O3 ; HAGHFELT, T4 ; KJEKSHUS, J1 ; MIETTINEN, T5 ; MUSLINER, T. A2 ; OLSSON, A. G6 ; PYORALA, K7
[1] University of Oslo, Norway
[2] Merck Research Laboratories, Rahway, NJ, United States
[3] Aarhus University Hospital, Denmark
[4] Odense Hospital, Denmark
[5] University of Helsinki, Finland
[6] University of Linköping, Sweden
[7] University of Kuopio, Finland
[8] Reykjavik University Hospital, Iceland
[9] University of Gothenburg, Sweden - Source
Archives of internal medicine (1960). 1996, Vol 156, Num 18, pp 2085-2092 ; ref : 27 ref
- CODEN
- AIMDAP
- ISSN
- 0003-9926
- Domaine scientifique
- General medicine general surgery
- Editeur
- American Medical Association, Chicago, IL
- Pays de publication
- United States
- Type de document
- Article
- Langue
- English
- Mot clé (fr)
- Chimiothérapie Homme Hypercholestérolémie Lipide Long terme Morbidité Mortalité Simvastatine Sécurité Tolérance Toxicité Pays Scandinaves Enzyme Hydroxymethylglutaryl-CoA reductase Hyperlipoprotéinémie Hypolipémiant Inhibiteur enzyme Métabolisme pathologie Oxidoreductases Europe
- Mot clé (en)
- Chemotherapy Human Hypercholesterolemia Lipids Long term Morbidity Mortality Safety Tolerance Toxicity Scandinavia Enzyme Hydroxymethylglutaryl-CoA reductase Hyperlipoproteinemia Antilipemic agent Enzyme inhibitor Metabolic diseases Oxidoreductases Europe
- Mot clé (es)
- Quimioterapia Hombre Hipercolesterolemia Lípido Largo plazo Morbilidad Mortalidad Seguridad Tolerancia Toxicidad Países escandinavos Enzima Hydroxymethylglutaryl-CoA reductase Hiperlipoproteinemia Hipolipemiante Inhibidor enzima Metabolismo patología Oxidoreductases Europa
- Classification
- Pascal
- 002 Sciences biologiques et medicales / 002B Sciences medicales / 002B02 Pharmacologie. Traitements medicamenteux / 002B02U Toxicité des médicaments et traitement des toxicités dues aux médicaments / 002B02U10 Divers (allergie médicamenteuse, mutagènes, tératogènes...)
- Discipline
- Drugs toxicity and drug intoxications Toxicology
- Provenance
- Inist-CNRS
- Base de données
- PASCAL
- Identifiant INIST
- 3248303
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Accès au Document
Installer sur votre navigateur
DOI
10.1001/archinte.1996.00440170097011 
https://dx.doi.org/10.1001/archinte.1996.00440170097011
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:36:\"10.1001\/archinte.1996.00440170097011\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:126:\"Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Archives of internal medicine (1960)\";s:9:\"\u0000*\u0000stitle\";s:25:\"Arch. intern. med. (1960)\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:3:\"156\";s:8:\"\u0000*\u0000issue\";s:2:\"18\";s:8:\"\u0000*\u0000spage\";s:4:\"2085\";s:8:\"\u0000*\u0000epage\";s:4:\"2092\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-9926\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"PEDERSEN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"T. R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:7:\"BERG, K\";i:1;s:15:\"THORGEIRSSON, G\";i:2;s:12:\"TOBERT, J. A\";i:3;s:8:\"WEDEL, H\";i:4;s:12:\"WIHELMSEN, L\";i:5;s:10:\"COOK, T. J\";i:6;s:12:\"FOERGEMAN, O\";i:7;s:11:\"HAGHFELT, T\";i:8;s:11:\"KJEKSHUS, J\";i:9;s:12:\"MIETTINEN, T\";i:10;s:14:\"MUSLINER, T. A\";i:11;s:12:\"OLSSON, A. G\";i:12;s:10:\"PYORALA, K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMDAP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:126:\"Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Accès par Panist
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:36:\"10.1001\/archinte.1996.00440170097011\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:126:\"Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Archives of internal medicine (1960)\";s:9:\"\u0000*\u0000stitle\";s:25:\"Arch. intern. med. (1960)\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:3:\"156\";s:8:\"\u0000*\u0000issue\";s:2:\"18\";s:8:\"\u0000*\u0000spage\";s:4:\"2085\";s:8:\"\u0000*\u0000epage\";s:4:\"2092\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-9926\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"PEDERSEN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"T. R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:7:\"BERG, K\";i:1;s:15:\"THORGEIRSSON, G\";i:2;s:12:\"TOBERT, J. A\";i:3;s:8:\"WEDEL, H\";i:4;s:12:\"WIHELMSEN, L\";i:5;s:10:\"COOK, T. J\";i:6;s:12:\"FOERGEMAN, O\";i:7;s:11:\"HAGHFELT, T\";i:8;s:11:\"KJEKSHUS, J\";i:9;s:12:\"MIETTINEN, T\";i:10;s:14:\"MUSLINER, T. A\";i:11;s:12:\"OLSSON, A. G\";i:12;s:10:\"PYORALA, K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMDAP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:126:\"Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Accès par Istex
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:36:\"10.1001\/archinte.1996.00440170097011\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Accès par Unpaywall
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:36:\"10.1001\/archinte.1996.00440170097011\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:126:\"Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Archives of internal medicine (1960)\";s:9:\"\u0000*\u0000stitle\";s:25:\"Arch. intern. med. (1960)\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:3:\"156\";s:8:\"\u0000*\u0000issue\";s:2:\"18\";s:8:\"\u0000*\u0000spage\";s:4:\"2085\";s:8:\"\u0000*\u0000epage\";s:4:\"2092\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-9926\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"PEDERSEN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"T. R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:7:\"BERG, K\";i:1;s:15:\"THORGEIRSSON, G\";i:2;s:12:\"TOBERT, J. A\";i:3;s:8:\"WEDEL, H\";i:4;s:12:\"WIHELMSEN, L\";i:5;s:10:\"COOK, T. J\";i:6;s:12:\"FOERGEMAN, O\";i:7;s:11:\"HAGHFELT, T\";i:8;s:11:\"KJEKSHUS, J\";i:9;s:12:\"MIETTINEN, T\";i:10;s:14:\"MUSLINER, T. A\";i:11;s:12:\"OLSSON, A. G\";i:12;s:10:\"PYORALA, K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMDAP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:126:\"Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Accès par Europe PubMed Central
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:36:\"10.1001\/archinte.1996.00440170097011\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:126:\"Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Archives of internal medicine (1960)\";s:9:\"\u0000*\u0000stitle\";s:25:\"Arch. intern. med. (1960)\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:3:\"156\";s:8:\"\u0000*\u0000issue\";s:2:\"18\";s:8:\"\u0000*\u0000spage\";s:4:\"2085\";s:8:\"\u0000*\u0000epage\";s:4:\"2092\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-9926\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"PEDERSEN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"T. R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:7:\"BERG, K\";i:1;s:15:\"THORGEIRSSON, G\";i:2;s:12:\"TOBERT, J. A\";i:3;s:8:\"WEDEL, H\";i:4;s:12:\"WIHELMSEN, L\";i:5;s:10:\"COOK, T. J\";i:6;s:12:\"FOERGEMAN, O\";i:7;s:11:\"HAGHFELT, T\";i:8;s:11:\"KJEKSHUS, J\";i:9;s:12:\"MIETTINEN, T\";i:10;s:14:\"MUSLINER, T. A\";i:11;s:12:\"OLSSON, A. G\";i:12;s:10:\"PYORALA, K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMDAP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:126:\"Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Accès par Base Search
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:36:\"10.1001\/archinte.1996.00440170097011\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:126:\"Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Archives of internal medicine (1960)\";s:9:\"\u0000*\u0000stitle\";s:25:\"Arch. intern. med. (1960)\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:3:\"156\";s:8:\"\u0000*\u0000issue\";s:2:\"18\";s:8:\"\u0000*\u0000spage\";s:4:\"2085\";s:8:\"\u0000*\u0000epage\";s:4:\"2092\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-9926\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"PEDERSEN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"T. R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:7:\"BERG, K\";i:1;s:15:\"THORGEIRSSON, G\";i:2;s:12:\"TOBERT, J. A\";i:3;s:8:\"WEDEL, H\";i:4;s:12:\"WIHELMSEN, L\";i:5;s:10:\"COOK, T. J\";i:6;s:12:\"FOERGEMAN, O\";i:7;s:11:\"HAGHFELT, T\";i:8;s:11:\"KJEKSHUS, J\";i:9;s:12:\"MIETTINEN, T\";i:10;s:14:\"MUSLINER, T. A\";i:11;s:12:\"OLSSON, A. G\";i:12;s:10:\"PYORALA, K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMDAP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:126:\"Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Accès par arXiv
